Potassium Infusion for Conversion of Atrial Fibrillation/-Flutter
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 143 participants.
Also called NCT01818583
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 143 participants
- Sponsor
- Diakonhjemmet Hospital
- Registry
-
NCT01818583
-
- Other papers using this trial's data
- Potassium infusion increases the likelihood of conversion of recent-onset atrial fibrillation-A single-blinded, randomized clinical trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Norway
- Registry status
- Completed
Technical summary
Registry record NCT01818583. Randomized; single masking; primary purpose treatment. Start 2013-03 (actual); primary completion 2017-11 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Potassium Infusion for Conversion of Atrial Fibrillation/-Flutter
- Condition
- Atrial Fibrillation
- Condition
- Atrial Flutter
- Intervention (Drug)
- Potassium chloride
- Intervention (Drug)
- Glucose 50 MG/ML
- Lead sponsor
- Diakonhjemmet Hospital
Record details
- Record id
cardio:ct-nct01818583- Content hash
3f580487a301d63f7a1724a26ed417a4a21aee8f680bb954e6862be92f6b9858